awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53065761-9B6C8AAC-F4CE-406F-B21B-380221AEACEA
Q53065761-9B6C8AAC-F4CE-406F-B21B-380221AEACEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53065761-9B6C8AAC-F4CE-406F-B21B-380221AEACEA
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma.
P2860
Q53065761-9B6C8AAC-F4CE-406F-B21B-380221AEACEA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53065761-9B6C8AAC-F4CE-406F-B21B-380221AEACEA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d6f11578491a58b85b46ad24fac78f290480cac
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).